4QP-33477-18318
4 vaccinations
7 coded responses
39 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 502 / IA
- Registered
- 2021-02-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-13
Registered in v-safe
-
2021-02-13
Dose 1 — Pfizer-BioNTech
- 2021-02-15
- 2021-02-16
-
2021-02-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
-
2021-03-06
Dose 2 — Pfizer-BioNTech
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-13
-
2021-03-20
Survey response — day 14, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-06-05
- 2021-09-04
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2022-03-06
Survey response — 12 months, dose 2MedDRA: Asthma, COVID-19, Pre-existing disease — Feeling: GoodFree text: My asthma has been more problematic since I had a bout with COVID-19 in January 2022. I have to use my rescue inhaler more frequently.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Dose 4 — Pfizer-BioNTech
-
2022-04-23
Survey response — day 0, dose 4MedDRA: Asthma, Pre-existing disease, SARS-CoV-2 test positive, Upper respiratory tract infection — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: I tested positive for COVID-19 on January 17, 2022. I have had repeated bouts with upper respiratory infection and my asthma symptoms have worsened to the point that I require a rescue inhaler at least once daily.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Survey response — days 1–6 daily, dose 4MedDRA: Cough, Wheezing — Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Coughing, mild wheezingMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-04-26
Survey response — days 1–6 daily, dose 4MedDRA: Cough — Feeling: Fair · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CoughingMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-04-28
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Abdominal painAdult check-in
- 2022-04-29
- 2022-04-30
- 2022-05-07
- 2022-05-14
- 2022-05-21
- 2022-05-28
- 2022-06-04
- 2022-07-23
-
2022-10-22
Survey response — 6 months, dose 4MedDRA: Asthma, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Repeated upper respiratory infections, about 6 weeks apart. Worsening asthma symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-25
Call successfulParticipant prefers to complete VAERS report online
-
2023-04-25
Survey response — 12 months, dose 4MedDRA: Cough, Fatigue, Headache, Neck pain, Tinnitus — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-25
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2023-04-26
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-04-23 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 6 — day 14, dose 2
Symptoms: Headaches
Release 11 — 12 months, dose 2
Symptoms: My asthma has been more problematic since I had a bout with COVID-19 in January 2022. I have to use my rescue inhaler more frequently.
Release 11 — day 0, dose 4
Systemic reaction (other): I tested positive for COVID-19 on January 17, 2022. I have had repeated bouts with upper respiratory infection and my asthma symptoms have worsened to the point that I require a rescue inhaler at least once daily.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Coughing, mild wheezing
Systemic reaction (other): Coughing
Release 12 — 6 months, dose 4
Symptoms: Repeated upper respiratory infections, about 6 weeks apart. Worsening asthma symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Asthma | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Upper respiratory tract infection | · | · | ✓ |
| SRO | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release